BiomX Inc. financial data

Symbol
PHGE on NYSE
Location
Dover, DE
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 19 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 219% % -41%
Return On Equity -274% % -209%
Return On Assets -125% % -347%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,593,703 shares -94%
Common Stock, Shares, Outstanding 1,593,703 shares 56%
Entity Public Float $11,899,466 USD -44%
Common Stock, Value, Issued $7,000 USD 17%
Weighted Average Number of Shares Outstanding, Basic 1,631,037 shares 133%
Weighted Average Number of Shares Outstanding, Diluted 1,631,037 shares 115%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $21,292,000 USD -14%
General and Administrative Expense $9,628,000 USD -18%
Operating Income (Loss) $41,466,000 USD 6.9%
Nonoperating Income (Expense) $84,000 USD -75%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $36,192,000 USD -104%
Income Tax Expense (Benefit) $7,000 USD
Net Income (Loss) Attributable to Parent $36,199,000 USD -104%
Earnings Per Share, Basic 22.19 USD/shares -13%
Earnings Per Share, Diluted 22.19 USD/shares -62%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,360,000 USD -74%
Other Assets, Current $463,000 USD -83%
Assets, Current $5,575,000 USD -73%
Property, Plant and Equipment, Net $3,004,000 USD -54%
Operating Lease, Right-of-Use Asset $2,091,000 USD -78%
Goodwill $801,000 USD
Other Assets, Noncurrent $96,000 USD
Assets $5,783,000 USD -87%
Accrued Liabilities, Current $720,000 USD -81%
Liabilities, Current $6,379,000 USD -23%
Contract with Customer, Liability, Noncurrent $1,976,000 USD 0%
Operating Lease, Liability, Noncurrent $5,287,000 USD -39%
Other Liabilities, Noncurrent $34,000 USD -79%
Retained Earnings (Accumulated Deficit) $216,896,000 USD -20%
Stockholders' Equity Attributable to Parent $1,302,000 USD -105%
Liabilities and Equity $5,783,000 USD -87%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $8,712,000 USD 23%
Net Cash Provided by (Used in) Financing Activities $11,913,000 USD -69%
Net Cash Provided by (Used in) Investing Activities $51,000 USD -92%
Common Stock, Shares Authorized 750,000,000 shares 0%
Common Stock, Shares, Issued 1,593,703 shares 56%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,955,000 USD -72%
Interest Paid, Excluding Capitalized Interest, Operating Activities $5,000 USD -100%
Deferred Tax Assets, Valuation Allowance $57,617,000 USD 18%
Deferred Tax Assets, Gross $64,457,000 USD 16%
Operating Lease, Liability $9,584,000 USD 145%
Depreciation $236,000 USD 3.1%
Lessee, Operating Lease, Liability, to be Paid $12,538,000 USD 164%
Property, Plant and Equipment, Gross $5,589,000 USD -47%
Operating Lease, Liability, Current $1,436,000 USD 27%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,983,000 USD 188%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,952,000 USD 184%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,954,000 USD 246%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,015,000 USD 193%
Deferred Tax Assets, Operating Loss Carryforwards $51,579,000 USD 21%
Preferred Stock, Shares Issued 147,512 shares -0.15%
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $5,048,000 USD 634%
Operating Lease, Payments $134,000 USD
Additional Paid in Capital $196,970,000 USD 5.8%
Preferred Stock, Shares Outstanding 147,512 shares -0.15%
Share-based Payment Arrangement, Expense $2,091,000 USD 13%
Interest Expense $2,689,000 USD 24%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%